Complete Filing Data
VisionWave Holdings, Inc. reported Profit Loss of -$6.55 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean VisionWave Holdings, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Net Income * | -$6.5M |
| Operating Income Loss | -$6.7M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$6.5M |
| Income Tax Expense Benefit | |
| Sales And Excise Tax Payable Current | |
| Operating Expenses | $6.7M |
| Income Tax Examination Penalties And Interest Expense | |
| General And Administrative Expense | $5.4M |
| Selling And Marketing Expense | $1.2M |
| Research And Development Expense | $156.5K |
| Interest Expense | $59.3K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$6.9M | -$434.3K | -$60.3K | -$203.7K | -$153.1K | -$28.2K | |
| Operating Income Loss | -$6.6M | -$340.6K | -$60.3K | -$203.7K | -$348.4K | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$6.9M | -$434.0K | -$203.7K | -$144.3K | |||
| Income Tax Expense Benefit | $336.00 | $8.8K | |||||
| Sales And Excise Tax Payable Current | $976.7K | $943.0K | $913.3K | $750.6K | |||
| Operating Expenses | $6.6M | $203.7K | |||||
| Income Tax Examination Penalties And Interest Expense | $20.2K | ||||||
| General And Administrative Expense | $4.7M | $143.8K | |||||
| Selling And Marketing Expense | $1.5M | $60.0K | |||||
| Research And Development Expense | $315.1K | ||||||
| Interest Expense | $142.5K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Stockholders Equity | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | ||
| Retained Earnings Accumulated Deficit | -$332.1K | |
| Liabilities | $84.1K | |
| Other Accounts Payable And Accrued Liabilities | $15.0K | |
| Liabilities Current | ||
| Liabilities And Stockholders Equity | $13.0K | |
| Common Stock Value | $110.0K | |
| Change In Fair Value Of Warrant Liabilities | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $2.3M | |
| Assets Current | $3.0K | |
| Assets | $13.0K | |
| Accretion Of Common Stock Subject To Possible Redemption To Redemption Values | ||
| Taxes Payable Current | ||
| Temporary Equity Carrying Amount Attributable To Parent | ||
| Excise Tax Imposed On Common Stock Redemptions | ||
| Deferred Underwriters Discount | $14.5M | $84.1K |
| Repayments Of Convertible Debt | ||
| Treasury Stock Value | ||
| Treasury Stock Common Shares | ||
| Investments | $10.0K | |
| Assets Held In Trust Noncurrent | ||
| Notes Payable | ||
| Loans And Leases Receivable Related Parties | ||
| Deferred Underwriters Discounts |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $3.1M | -$11.8M | -$7.0M | -$66.3K | -$274.8K | -$71.1K | -$4.7M | -$4.3M | -$3.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $2.6M | $2.3M | $885.00 | $0.00 | $111.4K | $3.0K | $29.7K | $232.3K | |
| Retained Earnings Accumulated Deficit | -$22.0M | -$15.1M | -$7.0M | -$66.3K | -$6.0M | ||||
| Liabilities | $15.3M | $14.5M | $7.5M | $66.3K | $5.7M | ||||
| Other Accounts Payable And Accrued Liabilities | $4.2M | $3.9M | $1.3M | $969.9K | |||||
| Liabilities Current | $15.3M | $14.5M | $6.3M | $66.3K | $5.4M | $3.1K | |||
| Liabilities And Stockholders Equity | $18.4M | $2.7M | $1.2M | $3.8M | |||||
| Common Stock Value | $165.2K | $145.2K | $39.6K | $39.6K | |||||
| Change In Fair Value Of Warrant Liabilities | -$19.9K | $4.1K | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $361.6K | $108.4K | |||||||
| Assets Current | $4.0M | $2.7M | $4.8K | $13.7K | |||||
| Assets | $18.4M | $2.7M | $1.2M | $3.8M | |||||
| Accretion Of Common Stock Subject To Possible Redemption To Redemption Values | -$15.8K | -$54.8K | -$230.0K | -$491.2K | |||||
| Taxes Payable Current | $1.0M | $994.7K | $955.9K | $888.4K | |||||
| Temporary Equity Carrying Amount Attributable To Parent | $608.3K | $1.6M | $4.1M | $31.8M | |||||
| Excise Tax Imposed On Common Stock Redemptions | -$9.7K | -$25.7K | -$151.3K | ||||||
| Deferred Underwriters Discount | $225.0K | $225.0K | |||||||
| Repayments Of Convertible Debt | $149.9K | ||||||||
| Treasury Stock Value | $14.4K | $14.4K | |||||||
| Treasury Stock Common Shares | 1.4M | 1.4M | |||||||
| Investments | $281.00 | $281.00 | |||||||
| Assets Held In Trust Noncurrent | $1.2M | $3.7M | |||||||
| Notes Payable | $5.6M | $4.9M | |||||||
| Loans And Leases Receivable Related Parties | $147.5K | $120.0K | |||||||
| Deferred Underwriters Discounts | $225.0K | $225.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Net Cash Provided By Used In Operating Activities | -$2.8M |
| Net Cash Provided By Used In Financing Activities | $5.0M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $3.3M |
| Net Cash Provided By Used In Investing Activities | $114.4K |
| Increase Decrease In Due To Related Parties | -$1.6M |
| Increase Decrease In Accrued Taxes Payable | $35.1K |
| Increase Decrease In Excise Tax Payable | $54.7K |
| Share Based Compensation | $2.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q4 2024 |
|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$5.4M | $108.4K |
| Net Cash Provided By Used In Financing Activities | $6.1M | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $258.0K | $45.0K |
| Net Cash Provided By Used In Investing Activities | -$329.5K | |
| Increase Decrease In Due To Related Parties | -$950.7K | |
| Increase Decrease In Accrued Taxes Payable | $24.8K | |
| Increase Decrease In Excise Tax Payable | $33.6K | |
| Share Based Compensation |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Common Stock Shares Issued | 200.0K | 11.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.01 |
| Common Stock Shares Outstanding | 11.0M | |
| Common Stock Shares Authorized | 150.0M | |
| Preferred Stock Shares Outstanding | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | |
| Preferred Stock Shares Authorized | 10.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.01 | |
| Basic And Diluted Weighted Average Shares Outstanding | 11.7M | |
| Basic And Diluted Net Loss Per Share | $-0.56 | |
| Temporary Equity Shares Authorized |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Common Stock Shares Issued | 16.5M | 14.5M | 4.1M | 1.00 | 4.3M | |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | ||
| Common Stock Shares Outstanding | 16.5M | 14.5M | 2.5M | 1.00 | 2.5M | |
| Common Stock Shares Authorized | 150.0M | 150.0M | 100.0M | 1.0K | 100.0M | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 1.0M | 1.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | ||
| Basic And Diluted Weighted Average Shares Outstanding | 15.2M | 2.6M | 11.0M | 4.1M | ||
| Basic And Diluted Net Loss Per Share | $-0.46 | $-0.17 | $-0.02 | $-0.04 | ||
| Temporary Equity Shares Authorized | 16.4K | 324.7K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Other Income | $193.1K | |
| Operating Costs And Expenses | ||
| Interest Income Operating | $418.00 | |
| Due To Related Parties | $69.1K | |
| Excise Tax Interestpenalty | ||
| Promissory Notes Evie | ||
| Prepaid Expense Current | $189.5K | |
| Promissory Notes | ||
| Extended Product Warranty Accrual | ||
| Additional Paid In Capital | $151.0K | |
| Supplies |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Other Income | $60.0K | -$93.3K | $204.1K | |||
| Operating Costs And Expenses | $340.6K | $60.3K | $348.4K | |||
| Interest Income Operating | $988.00 | $6.0K | $200.1K | |||
| Due To Related Parties | $1.5M | $2.4M | $2.2M | $47.6K | $1.8M | |
| Excise Tax Interestpenalty | $59.2K | $0.00 | ||||
| Promissory Notes Evie | $1.0M | $1.0M | ||||
| Prepaid Expense Current | $3.9K | $3.9K | ||||
| Promissory Notes | $1.0M | $1.0M | ||||
| Extended Product Warranty Accrual | $26.0K | $12.2K | ||||
| Additional Paid In Capital | $24.9M | $3.2M | ||||
| Supplies | $98.3K | $98.3K |
Most recent annual filing with the SEC: December 31, 2025
Data sourced from SEC EDGAR public filings as of August 8, 2026.